Skip to content

Neurobiomarker for Prism Adaptation Treatment Response

Development of a Neuroimaging Biomarker to Identify Optimal Candidates for Prism Adaptation Treatment

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04966000
Enrollment
0
Registered
2021-07-16
Start date
2023-01-01
Completion date
2024-12-05
Last updated
2025-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biomarker, Perceptual Disorders, Stroke

Keywords

stroke, Prism Adaptation Therapy, spatial neglect

Brief summary

Preliminary data will be collected about which individuals with spatial neglect from right hemisphere stroke (aiming vs perceptual neglect) improve with Prism Adaptation Training and if there is a particular pattern of damage in the brain that predicts both the type of neglect experienced and whether neglect is improved following Prism Adaptation Training

Detailed description

For preliminary data, twelve individuals with right hemisphere stroke and spatial neglect will participate. After pretesting for type of neglect and its severity, they will have an MRI with Diffusion Tensor Imaging (DTI). Then they will complete 10 sessions of Prism Adaptation Therapy and complete neglect post-testing. Response to Prism Adaptation Therapy will be assessed by comparing neglect scores pre- and post-training. Traditional lesion mapping, structural and functional lesion disconnectivity analyses, and tract-based spatial statistics of DTI measures will be used to examine whether any patterns of damage/dysfunction are related to a diagnosis of aiming neglect and response to Prism Adaptation Therapy.

Interventions

Participants wear goggles with built-in prisms (a 20-diopter lens) that shift the visual scene to the right. While wearing the googles they reach to and cross out 60 lines/circles, requiring them to learn to reach more leftward than the visual targets appear. Participants can only see the end of their movements.

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

a single group pre-post pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* 1\) within 1 month of right hemisphere stroke 2\) suspected of having unilateral spatial neglect 3\) able to provide consent 4\) likely to remain in rehabilitation for 10-12 days or willing to return to the University to complete 10 sessions of treatment and post-treatment testing 5\) able to have an MRI 6\) will be or has been admitted to the Craig H. Neilson Rehabilitation Hospital for rehabilitation or is able to come to the Craig H. Neilson Rehabilitation Hospital for prism adaptation therapy sessions. 7\) age 18-90 years 8\) able to sit in a wheelchair or other chair for 1 hour 9\) able to point straight ahead and hold a pen with right hand

Exclusion criteria

* 1\) other neurologic, medical that would interfere with ability to complete the testing or training 2\) no uncorrected visual or hearing problems, other than hemianopsia 3\) contraindications to MRI 4\) unable to provide consent due to significant aphasia or cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Catherine Bergego Scalebaseline before prism adaptation therapyasks the impact of neglect behavior on 20 everyday tasks using a 0-3 rating scale. Higher scores = more neglect impact. Total score is sum of item scores

Secondary

MeasureTime frameDescription
Behavioral Attention Test conventional subtestsbaseline pre-prism adaptation therapytraditional neuropsychological subtests (line crossing, letter cancelation, star cancellation, figure and shape copying, line bisection, and representational drawing). Total score is the sum of scores on subtests with highest score being 146. A score of 129 or higher indicates neglect

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026